PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Samsara Inc. (IOT)
33.600.80 (-2.33%)
33.44 - 34.57
31.40 - 61.90
7.61M / 5.95M (Avg.)
-152.73 | -0.22
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
9.45%
Net income growth at 50-75% of BRZE's 15.69%. Martin Whitman would worry about lagging competitiveness unless expansions are planned.
12.08%
Some D&A expansion while BRZE is negative at -3.11%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
No Data
No Data available this quarter, please select a different quarter.
1.67%
SBC growth well above BRZE's 1.83%. Michael Burry would flag major dilution risk vs. competitor’s approach.
24.10%
Slight usage while BRZE is negative at -122.46%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
234.18%
AR growth while BRZE is negative at -124.39%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
132.91%
Inventory growth of 132.91% while BRZE is zero at 0.00%. Bruce Berkowitz would see a moderate build that must match future sales to avoid risk.
-163.74%
Negative yoy AP while BRZE is 1878.57%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
107.85%
Some yoy usage while BRZE is negative at -124.26%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
-75.89%
Both negative yoy, with BRZE at -44.66%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
24.20%
Some CFO growth while BRZE is negative at -191.07%. John Neff would note a short-term liquidity lead over the competitor.
41.30%
Some CapEx rise while BRZE is negative at -268.98%. John Neff would see competitor possibly building capacity while we hold back expansions.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
41.30%
Lower net investing outflow yoy vs. BRZE's 100.98%, preserving short-term cash. David Dodd would confirm expansions remain sufficient.
-2.07%
We cut debt repayment yoy while BRZE is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
3911.65%
Stock issuance far above BRZE's 5.74%. Michael Burry flags a significant dilution risk vs. competitor’s approach unless ROI is very high.
No Data
No Data available this quarter, please select a different quarter.